Matthew Meyerson

49PUBLICATIONS
323CO-AUTHORS
Molecular targetsPreventative health careCancer geneticsHaematological tumoursHealth and ecological risk assessment
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (49)

|Jul 01, 2026
U2AF1 mutations rescue deleterious exon skipping induced by KRAS mutations.

|Jun 02, 2026
Preclinical response of uveal melanomas to the velcrin compound, BAY 2666605.

|May 18, 2026
Aneuploidy sensitizes cells to SREBP-pathway inhibition in squamous cell carcinoma.

|Apr 19, 2026
A Roadmap to Transform Lung Cancer Outcomes: Priorities in Biology, Therapeutic Innovation, Early Detection, Prevention, and Interception.

|Nov 12, 2025
Publisher Correction: Mutant p53 protein accumulation is selectively targetable by proximity-inducing drugs.

Ananthan Sadagopan, Maximilian Carson, Eriks J Zamurs

|Nov 03, 2025
Mutant p53 protein accumulation is selectively targetable by proximity-inducing drugs.

Ananthan Sadagopan, Maximilian Carson, Eriks J Zamurs

Pageof 9

Frequent Collaborators

13 joint publications

Andrew D Cherniack

6 joint publications

Gad Getz

6 joint publications

Yvonne Y Li

5 joint publications

Aviad Tsherniak